{"status": "Succeeded", "recognitionResults": [{"page": 1, "clockwiseOrientation": 0.05, "width": 1700, "height": 2236, "unit": "pixel", "lines": [{"boundingBox": [208, 132, 397, 137, 395, 186, 206, 180], "text": "Takeda", "words": [{"boundingBox": [247, 134, 389, 139, 390, 183, 247, 181], "text": "Takeda"}]}, {"boundingBox": [1156, 244, 1393, 243, 1394, 274, 1157, 275], "text": "19 January 2012", "words": [{"boundingBox": [1160, 245, 1193, 246, 1195, 275, 1162, 274], "text": "19", "confidence": "Low"}, {"boundingBox": [1217, 246, 1324, 245, 1326, 275, 1219, 275], "text": "January"}, {"boundingBox": [1330, 245, 1393, 244, 1395, 274, 1332, 275], "text": "2012"}]}, {"boundingBox": [178, 314, 1373, 315, 1372, 345, 177, 344], "text": "Direct Healthcare Professional Communication on pioglitazone and a small increased risk of.", "words": [{"boundingBox": [182, 315, 264, 315, 265, 343, 182, 343], "text": "Direct"}, {"boundingBox": [270, 315, 413, 316, 414, 344, 270, 343], "text": "Healthcare", "confidence": "Low"}, {"boundingBox": [418, 316, 580, 316, 581, 345, 419, 344], "text": "Professional"}, {"boundingBox": [585, 316, 791, 316, 792, 345, 586, 345], "text": "Communication"}, {"boundingBox": [798, 316, 831, 316, 832, 345, 799, 345], "text": "on"}, {"boundingBox": [837, 316, 994, 316, 996, 345, 838, 345], "text": "pioglitazone"}, {"boundingBox": [1000, 316, 1051, 316, 1052, 345, 1001, 345], "text": "and"}, {"boundingBox": [1057, 316, 1073, 316, 1074, 344, 1058, 345], "text": "a"}, {"boundingBox": [1079, 316, 1148, 316, 1150, 344, 1080, 344], "text": "small"}, {"boundingBox": [1154, 316, 1279, 316, 1280, 343, 1155, 344], "text": "increased"}, {"boundingBox": [1284, 316, 1336, 316, 1337, 342, 1286, 343], "text": "risk"}, {"boundingBox": [1341, 316, 1370, 315, 1372, 342, 1342, 342], "text": "of.", "confidence": "Low"}]}, {"boundingBox": [186, 349, 501, 350, 500, 381, 185, 380], "text": "Urinary Bladder Cancer.", "words": [{"boundingBox": [186, 354, 287, 351, 287, 378, 186, 381], "text": "Urinary", "confidence": "Low"}, {"boundingBox": [292, 351, 398, 351, 399, 378, 293, 378], "text": "Bladder"}, {"boundingBox": [404, 351, 499, 355, 500, 380, 404, 378], "text": "Cancer."}]}, {"boundingBox": [178, 415, 540, 417, 539, 447, 177, 446], "text": "Dear Healthcare Professional,", "words": [{"boundingBox": [181, 416, 241, 417, 242, 446, 183, 446], "text": "Dear"}, {"boundingBox": [247, 417, 379, 417, 380, 447, 248, 446], "text": "Healthcare"}, {"boundingBox": [385, 417, 539, 418, 539, 447, 386, 447], "text": "Professional,"}]}, {"boundingBox": [180, 487, 312, 489, 311, 517, 179, 516], "text": "Summary", "words": [{"boundingBox": [183, 488, 311, 489, 313, 517, 184, 515], "text": "Summary"}]}, {"boundingBox": [174, 553, 1357, 553, 1358, 587, 175, 588], "text": "Following the letter that was sent to you in July 2011, this communication is to inform you of the", "words": [{"boundingBox": [181, 554, 305, 555, 305, 587, 181, 586], "text": "Following"}, {"boundingBox": [311, 555, 351, 555, 350, 587, 311, 587], "text": "the"}, {"boundingBox": [357, 555, 421, 555, 420, 588, 356, 587], "text": "letter"}, {"boundingBox": [427, 555, 474, 555, 474, 588, 427, 588], "text": "that"}, {"boundingBox": [481, 555, 528, 555, 528, 588, 480, 588], "text": "was"}, {"boundingBox": [534, 555, 584, 555, 584, 588, 534, 588], "text": "sent"}, {"boundingBox": [590, 555, 617, 555, 617, 588, 590, 588], "text": "to"}, {"boundingBox": [623, 555, 667, 555, 666, 589, 623, 588], "text": "you"}, {"boundingBox": [673, 555, 698, 555, 697, 589, 672, 589], "text": "in"}, {"boundingBox": [704, 555, 756, 555, 755, 589, 703, 589], "text": "July"}, {"boundingBox": [762, 555, 832, 555, 831, 589, 761, 589], "text": "2011,"}, {"boundingBox": [838, 555, 884, 555, 883, 589, 838, 589], "text": "this"}, {"boundingBox": [890, 555, 1076, 554, 1075, 588, 889, 589], "text": "communication"}, {"boundingBox": [1082, 554, 1105, 554, 1104, 588, 1081, 588], "text": "is"}, {"boundingBox": [1111, 554, 1136, 554, 1135, 588, 1110, 588], "text": "to"}, {"boundingBox": [1142, 554, 1221, 554, 1220, 587, 1141, 588], "text": "inform"}, {"boundingBox": [1233, 554, 1278, 553, 1277, 587, 1232, 587], "text": "you"}, {"boundingBox": [1285, 553, 1309, 553, 1308, 587, 1284, 587], "text": "of"}, {"boundingBox": [1316, 553, 1357, 553, 1356, 586, 1315, 587], "text": "the"}]}, {"boundingBox": [175, 587, 1281, 588, 1280, 622, 174, 621], "text": "confirmed updated Summary of Product Characteristics (SmPC) wording for pioglitazone", "words": [{"boundingBox": [182, 590, 306, 589, 305, 622, 181, 621], "text": "confirmed"}, {"boundingBox": [312, 589, 412, 589, 410, 622, 311, 622], "text": "updated"}, {"boundingBox": [418, 589, 536, 588, 534, 622, 416, 622], "text": "Summary"}, {"boundingBox": [542, 588, 568, 588, 566, 622, 540, 622], "text": "of"}, {"boundingBox": [574, 588, 670, 588, 668, 622, 572, 622], "text": "Product"}, {"boundingBox": [676, 588, 857, 588, 854, 622, 674, 622], "text": "Characteristics"}, {"boundingBox": [863, 588, 962, 588, 960, 622, 861, 622], "text": "(SmPC)"}, {"boundingBox": [968, 588, 1070, 589, 1068, 622, 966, 622], "text": "wording"}, {"boundingBox": [1076, 589, 1112, 589, 1110, 622, 1074, 622], "text": "for"}, {"boundingBox": [1118, 589, 1273, 590, 1270, 622, 1116, 622], "text": "pioglitazone"}]}, {"boundingBox": [179, 623, 1347, 622, 1348, 655, 180, 656], "text": "containing products* as well as the provision of a Prescriber's Guide Since the letter sent in July", "words": [{"boundingBox": [183, 624, 309, 625, 308, 655, 182, 654], "text": "containing"}, {"boundingBox": [315, 625, 438, 624, 438, 656, 314, 655], "text": "products*", "confidence": "Low"}, {"boundingBox": [444, 624, 471, 624, 471, 656, 444, 656], "text": "as"}, {"boundingBox": [477, 624, 529, 624, 529, 656, 477, 656], "text": "well"}, {"boundingBox": [535, 624, 562, 624, 562, 656, 535, 656], "text": "as"}, {"boundingBox": [568, 624, 607, 624, 606, 656, 568, 656], "text": "the"}, {"boundingBox": [612, 624, 726, 624, 726, 657, 612, 656], "text": "provision"}, {"boundingBox": [732, 624, 759, 624, 759, 657, 732, 657], "text": "of"}, {"boundingBox": [765, 624, 780, 624, 781, 657, 765, 657], "text": "a"}, {"boundingBox": [786, 624, 933, 624, 934, 656, 786, 657], "text": "Prescriber's"}, {"boundingBox": [939, 624, 1018, 624, 1019, 656, 939, 656], "text": "Guide", "confidence": "Low"}, {"boundingBox": [1028, 624, 1096, 624, 1096, 655, 1029, 656], "text": "Since"}, {"boundingBox": [1101, 624, 1138, 624, 1139, 655, 1102, 655], "text": "the"}, {"boundingBox": [1144, 624, 1212, 623, 1213, 655, 1145, 655], "text": "letter"}, {"boundingBox": [1217, 623, 1266, 623, 1267, 654, 1218, 655], "text": "sent"}, {"boundingBox": [1272, 623, 1297, 623, 1298, 654, 1273, 654], "text": "in"}, {"boundingBox": [1302, 623, 1347, 623, 1348, 653, 1304, 654], "text": "July"}]}, {"boundingBox": [173, 656, 1347, 654, 1347, 689, 174, 692], "text": "201.1, the European Medicines Agency has amended the wording of Section 4.1 of the SmPC to", "words": [{"boundingBox": [183, 658, 252, 659, 251, 690, 182, 690], "text": "201.1,", "confidence": "Low"}, {"boundingBox": [258, 659, 295, 659, 294, 690, 257, 690], "text": "the"}, {"boundingBox": [301, 659, 417, 660, 417, 691, 300, 690], "text": "European"}, {"boundingBox": [423, 660, 554, 660, 553, 691, 423, 691], "text": "Medicines"}, {"boundingBox": [560, 660, 653, 660, 653, 691, 560, 691], "text": "Agency"}, {"boundingBox": [660, 660, 701, 660, 701, 691, 659, 691], "text": "has"}, {"boundingBox": [707, 660, 817, 660, 817, 691, 707, 691], "text": "amended"}, {"boundingBox": [823, 659, 862, 659, 862, 691, 823, 691], "text": "the"}, {"boundingBox": [869, 659, 970, 659, 970, 691, 868, 691], "text": "wording"}, {"boundingBox": [976, 659, 1005, 658, 1005, 691, 976, 691], "text": "of"}, {"boundingBox": [1011, 658, 1101, 657, 1101, 690, 1012, 691], "text": "Section"}, {"boundingBox": [1107, 657, 1144, 657, 1144, 690, 1107, 690], "text": "4.1", "confidence": "Low"}, {"boundingBox": [1150, 657, 1177, 657, 1177, 690, 1150, 690], "text": "of"}, {"boundingBox": [1183, 657, 1223, 656, 1223, 690, 1184, 690], "text": "the"}, {"boundingBox": [1229, 656, 1305, 655, 1306, 689, 1229, 690], "text": "SmPC"}, {"boundingBox": [1312, 655, 1343, 654, 1343, 689, 1312, 689], "text": "to", "confidence": "Low"}]}, {"boundingBox": [178, 692, 1309, 690, 1310, 724, 179, 726], "text": "emphasize that pioglitazone should not be used first line. In addition, Section 1 of the Patient", "words": [{"boundingBox": [183, 694, 309, 694, 309, 725, 183, 724], "text": "emphasize"}, {"boundingBox": [315, 694, 363, 693, 363, 725, 315, 725], "text": "that"}, {"boundingBox": [369, 693, 520, 693, 520, 726, 369, 725], "text": "pioglitazone"}, {"boundingBox": [526, 693, 606, 693, 606, 726, 526, 726], "text": "should"}, {"boundingBox": [612, 693, 654, 692, 654, 726, 612, 726], "text": "not"}, {"boundingBox": [660, 692, 688, 692, 688, 726, 660, 726], "text": "be"}, {"boundingBox": [694, 692, 752, 692, 752, 726, 694, 726], "text": "used"}, {"boundingBox": [758, 692, 808, 692, 808, 726, 758, 726], "text": "first"}, {"boundingBox": [814, 692, 868, 692, 868, 726, 814, 726], "text": "line.", "confidence": "Low"}, {"boundingBox": [874, 692, 902, 692, 902, 725, 874, 726], "text": "In"}, {"boundingBox": [908, 692, 1017, 692, 1017, 725, 908, 725], "text": "addition,"}, {"boundingBox": [1023, 692, 1115, 691, 1115, 725, 1023, 725], "text": "Section"}, {"boundingBox": [1121, 691, 1135, 691, 1135, 724, 1121, 725], "text": "1", "confidence": "Low"}, {"boundingBox": [1141, 691, 1167, 691, 1167, 724, 1141, 724], "text": "of"}, {"boundingBox": [1173, 691, 1213, 691, 1213, 724, 1173, 724], "text": "the"}, {"boundingBox": [1219, 691, 1309, 691, 1309, 723, 1219, 724], "text": "Patient"}]}, {"boundingBox": [176, 725, 1370, 724, 1371, 757, 177, 759], "text": "Information Leaflet has been updated to state pioglitazone should be used when metformin is not", "words": [{"boundingBox": [181, 726, 325, 726, 325, 759, 181, 758], "text": "Information"}, {"boundingBox": [331, 726, 418, 726, 418, 759, 331, 759], "text": "Leaflet", "confidence": "Low"}, {"boundingBox": [424, 726, 467, 727, 466, 759, 424, 759], "text": "has"}, {"boundingBox": [473, 727, 530, 727, 529, 759, 472, 759], "text": "been"}, {"boundingBox": [536, 727, 636, 727, 635, 759, 536, 759], "text": "updated"}, {"boundingBox": [642, 726, 667, 726, 667, 759, 641, 759], "text": "to"}, {"boundingBox": [674, 726, 729, 726, 728, 759, 673, 759], "text": "state"}, {"boundingBox": [735, 726, 885, 726, 884, 759, 734, 759], "text": "pioglitazone"}, {"boundingBox": [892, 726, 972, 726, 971, 759, 890, 759], "text": "should"}, {"boundingBox": [978, 726, 1008, 726, 1006, 758, 977, 759], "text": "be"}, {"boundingBox": [1014, 726, 1071, 725, 1070, 758, 1013, 758], "text": "used"}, {"boundingBox": [1078, 725, 1143, 725, 1142, 758, 1076, 758], "text": "when"}, {"boundingBox": [1150, 725, 1276, 724, 1274, 758, 1148, 758], "text": "metformin"}, {"boundingBox": [1283, 724, 1306, 724, 1304, 758, 1281, 758], "text": "is"}, {"boundingBox": [1312, 724, 1363, 724, 1361, 757, 1310, 758], "text": "not", "confidence": "Low"}]}, {"boundingBox": [156, 759, 1352, 757, 1353, 790, 157, 792], "text": "suitable or has failed to work adequately and additional heart failure, oedema, bone fracture and", "words": [{"boundingBox": [183, 761, 277, 760, 275, 792, 182, 793], "text": "suitable", "confidence": "Low"}, {"boundingBox": [283, 760, 308, 760, 307, 792, 282, 792], "text": "or"}, {"boundingBox": [315, 760, 358, 760, 357, 792, 313, 792], "text": "has"}, {"boundingBox": [365, 760, 433, 759, 432, 792, 363, 792], "text": "failed"}, {"boundingBox": [439, 759, 466, 759, 465, 792, 438, 792], "text": "to"}, {"boundingBox": [473, 759, 535, 759, 534, 792, 471, 792], "text": "work"}, {"boundingBox": [541, 759, 672, 759, 671, 792, 540, 792], "text": "adequately"}, {"boundingBox": [679, 759, 722, 758, 721, 792, 677, 792], "text": "and"}, {"boundingBox": [729, 758, 851, 758, 850, 792, 727, 792], "text": "additional"}, {"boundingBox": [858, 758, 920, 758, 919, 792, 856, 792], "text": "heart"}, {"boundingBox": [926, 758, 1014, 758, 1012, 792, 925, 792], "text": "failure,"}, {"boundingBox": [1020, 758, 1120, 758, 1119, 792, 1019, 792], "text": "oedema,", "confidence": "Low"}, {"boundingBox": [1126, 758, 1189, 758, 1187, 792, 1125, 792], "text": "bone"}, {"boundingBox": [1195, 758, 1288, 759, 1287, 792, 1194, 792], "text": "fracture"}, {"boundingBox": [1295, 759, 1347, 759, 1346, 792, 1294, 792], "text": "and", "confidence": "Low"}]}, {"boundingBox": [182, 793, 1228, 794, 1227, 827, 181, 826], "text": "blurred vision wording has been added to Section 4 of the Patient Information Leaflet.", "words": [{"boundingBox": [182, 794, 271, 794, 272, 826, 184, 825], "text": "blurred"}, {"boundingBox": [277, 794, 352, 795, 353, 826, 278, 826], "text": "vision"}, {"boundingBox": [358, 795, 457, 795, 458, 827, 359, 826], "text": "wording"}, {"boundingBox": [463, 795, 505, 795, 506, 827, 464, 827], "text": "has"}, {"boundingBox": [511, 795, 572, 795, 573, 827, 512, 827], "text": "been"}, {"boundingBox": [578, 795, 651, 795, 651, 827, 579, 827], "text": "added"}, {"boundingBox": [657, 795, 683, 795, 684, 827, 657, 827], "text": "to"}, {"boundingBox": [689, 795, 780, 795, 780, 828, 690, 827], "text": "Section"}, {"boundingBox": [786, 795, 802, 795, 802, 827, 786, 828], "text": "4"}, {"boundingBox": [808, 795, 833, 795, 833, 827, 808, 827], "text": "of"}, {"boundingBox": [839, 795, 879, 795, 879, 827, 839, 827], "text": "the"}, {"boundingBox": [885, 795, 970, 795, 970, 827, 885, 827], "text": "Patient"}, {"boundingBox": [976, 795, 1119, 795, 1119, 826, 976, 827], "text": "Information"}, {"boundingBox": [1125, 795, 1226, 795, 1226, 826, 1125, 826], "text": "Leaflet."}]}, {"boundingBox": [177, 862, 1263, 864, 1262, 898, 176, 896], "text": "Takeda Pharmaceuticals Europe Lid informed you of safety data concerning pioglitazone", "words": [{"boundingBox": [185, 863, 273, 863, 271, 895, 183, 895], "text": "Takeda"}, {"boundingBox": [279, 863, 477, 863, 475, 897, 278, 895], "text": "Pharmaceuticals"}, {"boundingBox": [483, 864, 573, 864, 572, 897, 482, 897], "text": "Europe"}, {"boundingBox": [580, 864, 628, 864, 627, 897, 579, 897], "text": "Lid", "confidence": "Low"}, {"boundingBox": [634, 864, 745, 864, 745, 897, 633, 897], "text": "informed", "confidence": "Low"}, {"boundingBox": [752, 864, 798, 864, 797, 897, 751, 897], "text": "you"}, {"boundingBox": [804, 865, 832, 865, 831, 897, 804, 897], "text": "of"}, {"boundingBox": [838, 865, 913, 865, 913, 897, 837, 897], "text": "safety"}, {"boundingBox": [920, 865, 970, 865, 970, 897, 919, 897], "text": "data"}, {"boundingBox": [976, 865, 1109, 865, 1109, 896, 976, 897], "text": "concerning"}, {"boundingBox": [1115, 865, 1262, 866, 1262, 895, 1115, 896], "text": "pioglitazone"}]}, {"boundingBox": [183, 896, 1358, 893, 1359, 927, 184, 930], "text": "containing products*. New epidemiological data and a meta-analysis of randomized clinical trials", "words": [{"boundingBox": [185, 897, 310, 896, 310, 929, 184, 928], "text": "containing"}, {"boundingBox": [316, 896, 444, 896, 443, 929, 316, 929], "text": "products*.", "confidence": "Low"}, {"boundingBox": [450, 896, 507, 896, 507, 929, 450, 929], "text": "New"}, {"boundingBox": [515, 896, 715, 896, 715, 929, 515, 929], "text": "epidemiological"}, {"boundingBox": [721, 896, 768, 896, 768, 929, 721, 929], "text": "data"}, {"boundingBox": [774, 896, 817, 896, 818, 929, 774, 929], "text": "and"}, {"boundingBox": [824, 896, 840, 896, 840, 929, 824, 929], "text": "a"}, {"boundingBox": [846, 896, 1012, 895, 1013, 928, 846, 929], "text": "meta-analysis"}, {"boundingBox": [1019, 895, 1043, 895, 1044, 927, 1019, 928], "text": "of"}, {"boundingBox": [1049, 895, 1195, 895, 1196, 926, 1050, 927], "text": "randomized"}, {"boundingBox": [1201, 895, 1290, 895, 1290, 925, 1202, 926], "text": "clinical"}, {"boundingBox": [1296, 895, 1358, 895, 1358, 924, 1296, 925], "text": "trials"}]}, {"boundingBox": [177, 929, 1234, 930, 1233, 962, 176, 961], "text": "became available which indicated a small increased risk of urinary bladder cancer with", "words": [{"boundingBox": [181, 931, 275, 931, 276, 960, 182, 958], "text": "became"}, {"boundingBox": [280, 931, 390, 930, 392, 961, 282, 960], "text": "available"}, {"boundingBox": [396, 930, 472, 930, 474, 961, 397, 961], "text": "which"}, {"boundingBox": [478, 930, 591, 930, 593, 962, 479, 961], "text": "indicated"}, {"boundingBox": [597, 930, 613, 930, 614, 962, 598, 962], "text": "a"}, {"boundingBox": [618, 930, 682, 930, 684, 962, 620, 962], "text": "small"}, {"boundingBox": [687, 930, 805, 930, 806, 962, 689, 962], "text": "increased"}, {"boundingBox": [810, 930, 858, 930, 860, 962, 812, 962], "text": "risk"}, {"boundingBox": [864, 930, 890, 930, 892, 962, 865, 962], "text": "of"}, {"boundingBox": [896, 930, 985, 931, 986, 961, 897, 962], "text": "urinary"}, {"boundingBox": [990, 931, 1082, 931, 1084, 961, 991, 961], "text": "bladder"}, {"boundingBox": [1088, 931, 1169, 932, 1171, 960, 1089, 961], "text": "cancer"}, {"boundingBox": [1175, 932, 1230, 932, 1232, 959, 1176, 960], "text": "with"}]}, {"boundingBox": [182, 966, 1357, 965, 1358, 996, 183, 997], "text": "pioglitazone-containing products, Other known risk factors for bladder cancer are age, smoking", "words": [{"boundingBox": [183, 968, 469, 967, 470, 997, 183, 996], "text": "pioglitazone-containing"}, {"boundingBox": [475, 967, 605, 967, 605, 997, 475, 997], "text": "products,", "confidence": "Low"}, {"boundingBox": [611, 967, 680, 967, 680, 997, 611, 997], "text": "Other"}, {"boundingBox": [685, 967, 769, 966, 769, 998, 685, 997], "text": "known"}, {"boundingBox": [775, 966, 823, 966, 823, 998, 775, 998], "text": "risk"}, {"boundingBox": [828, 966, 912, 966, 912, 997, 829, 998], "text": "factors", "confidence": "Low"}, {"boundingBox": [918, 966, 955, 966, 955, 997, 918, 997], "text": "for"}, {"boundingBox": [961, 966, 1054, 966, 1054, 997, 961, 997], "text": "bladder"}, {"boundingBox": [1059, 966, 1137, 966, 1137, 997, 1059, 997], "text": "cancer"}, {"boundingBox": [1143, 966, 1186, 966, 1186, 997, 1143, 997], "text": "are"}, {"boundingBox": [1197, 966, 1249, 966, 1249, 997, 1197, 997], "text": "age,"}, {"boundingBox": [1255, 966, 1359, 966, 1359, 997, 1255, 997], "text": "smoking"}]}, {"boundingBox": [179, 1000, 1339, 999, 1340, 1031, 180, 1032], "text": "history, exposure to some occupational or chemotherapy agents e g. cyclophosphamide or prior", "words": [{"boundingBox": [182, 1001, 275, 1001, 276, 1031, 183, 1030], "text": "history,"}, {"boundingBox": [281, 1001, 389, 1001, 390, 1032, 282, 1031], "text": "exposure"}, {"boundingBox": [395, 1001, 422, 1001, 423, 1032, 396, 1032], "text": "to"}, {"boundingBox": [428, 1001, 492, 1001, 493, 1032, 429, 1032], "text": "some"}, {"boundingBox": [498, 1001, 654, 1001, 655, 1033, 498, 1032], "text": "occupational", "confidence": "Low"}, {"boundingBox": [660, 1001, 687, 1001, 688, 1033, 661, 1033], "text": "or"}, {"boundingBox": [693, 1001, 863, 1001, 864, 1033, 694, 1033], "text": "chemotherapy"}, {"boundingBox": [869, 1001, 950, 1001, 951, 1032, 870, 1033], "text": "agents"}, {"boundingBox": [956, 1001, 972, 1001, 972, 1032, 957, 1032], "text": "e"}, {"boundingBox": [977, 1001, 1001, 1001, 1001, 1032, 978, 1032], "text": "g.", "confidence": "Low"}, {"boundingBox": [1006, 1001, 1233, 1000, 1234, 1031, 1007, 1032], "text": "cyclophosphamide"}, {"boundingBox": [1239, 1000, 1266, 1000, 1267, 1031, 1240, 1031], "text": "or"}, {"boundingBox": [1272, 1000, 1337, 1000, 1338, 1030, 1272, 1031], "text": "prior"}]}, {"boundingBox": [173, 1033, 1378, 1031, 1379, 1063, 174, 1064], "text": "\"radiation treatment in the pelvic region. Annex A lists the revisions to the product information, full", "words": [{"boundingBox": [175, 1034, 290, 1034, 289, 1063, 174, 1063], "text": "\"radiation", "confidence": "Low"}, {"boundingBox": [295, 1034, 411, 1034, 410, 1064, 295, 1064], "text": "treatment"}, {"boundingBox": [416, 1034, 442, 1034, 442, 1064, 416, 1064], "text": "in"}, {"boundingBox": [448, 1034, 487, 1034, 487, 1064, 447, 1064], "text": "the"}, {"boundingBox": [493, 1034, 569, 1034, 568, 1065, 492, 1064], "text": "pelvic"}, {"boundingBox": [574, 1034, 664, 1034, 663, 1065, 574, 1065], "text": "region.", "confidence": "Low"}, {"boundingBox": [669, 1034, 751, 1034, 750, 1065, 669, 1065], "text": "Annex"}, {"boundingBox": [757, 1034, 775, 1034, 775, 1065, 756, 1065], "text": "A"}, {"boundingBox": [783, 1034, 835, 1034, 834, 1065, 782, 1065], "text": "lists"}, {"boundingBox": [840, 1034, 879, 1034, 879, 1065, 840, 1065], "text": "the"}, {"boundingBox": [885, 1034, 995, 1033, 994, 1065, 884, 1065], "text": "revisions"}, {"boundingBox": [1000, 1033, 1026, 1033, 1026, 1065, 1000, 1065], "text": "to"}, {"boundingBox": [1032, 1033, 1069, 1033, 1068, 1064, 1031, 1065], "text": "the"}, {"boundingBox": [1075, 1033, 1169, 1033, 1169, 1064, 1074, 1064], "text": "product"}, {"boundingBox": [1175, 1033, 1327, 1032, 1327, 1063, 1174, 1064], "text": "information,", "confidence": "Low"}, {"boundingBox": [1333, 1032, 1380, 1032, 1379, 1063, 1332, 1063], "text": "full"}]}, {"boundingBox": [171, 1065, 1375, 1065, 1375, 1099, 172, 1099], "text": "\"product information is available at https:/www.takeda co.uk/healthcare_professionals/CHMP aspx", "words": [{"boundingBox": [173, 1068, 275, 1068, 274, 1097, 172, 1097], "text": "\"product", "confidence": "Low"}, {"boundingBox": [280, 1068, 424, 1068, 424, 1098, 280, 1097], "text": "information"}, {"boundingBox": [430, 1068, 453, 1068, 453, 1098, 430, 1098], "text": "is"}, {"boundingBox": [459, 1068, 570, 1067, 570, 1098, 459, 1098], "text": "available"}, {"boundingBox": [576, 1067, 599, 1067, 599, 1098, 576, 1098], "text": "at"}, {"boundingBox": [605, 1067, 841, 1067, 841, 1098, 605, 1098], "text": "https:/www.takeda", "confidence": "Low"}, {"boundingBox": [847, 1067, 1314, 1066, 1314, 1100, 847, 1098], "text": "co.uk/healthcare_professionals/CHMP", "confidence": "Low"}, {"boundingBox": [1320, 1066, 1374, 1065, 1374, 1100, 1320, 1100], "text": "aspx"}]}, {"boundingBox": [171, 1100, 1155, 1100, 1155, 1131, 172, 1132], "text": "and will be available on the electronic Medicines Compendium (eMC) website", "words": [{"boundingBox": [183, 1102, 229, 1102, 227, 1132, 182, 1132], "text": "and", "confidence": "Low"}, {"boundingBox": [234, 1102, 280, 1102, 279, 1132, 233, 1132], "text": "will"}, {"boundingBox": [286, 1102, 318, 1102, 317, 1132, 285, 1132], "text": "be"}, {"boundingBox": [324, 1102, 433, 1102, 432, 1132, 322, 1132], "text": "available"}, {"boundingBox": [438, 1102, 470, 1102, 469, 1133, 437, 1132], "text": "on"}, {"boundingBox": [476, 1102, 516, 1102, 515, 1133, 475, 1133], "text": "the"}, {"boundingBox": [522, 1102, 642, 1102, 642, 1133, 521, 1133], "text": "electronic"}, {"boundingBox": [648, 1102, 775, 1102, 774, 1133, 648, 1133], "text": "Medicines"}, {"boundingBox": [781, 1102, 941, 1102, 941, 1133, 780, 1133], "text": "Compendium"}, {"boundingBox": [951, 1101, 1035, 1101, 1034, 1133, 951, 1133], "text": "(eMC)"}, {"boundingBox": [1041, 1101, 1138, 1100, 1137, 1133, 1040, 1133], "text": "website", "confidence": "Low"}]}, {"boundingBox": [174, 1134, 751, 1133, 752, 1168, 175, 1170], "text": "www.medicines. org uk from 21\" January 2012.", "words": [{"boundingBox": [183, 1140, 377, 1136, 377, 1169, 182, 1169], "text": "www.medicines.", "confidence": "Low"}, {"boundingBox": [383, 1136, 426, 1135, 426, 1169, 383, 1169], "text": "org"}, {"boundingBox": [432, 1135, 465, 1135, 465, 1169, 431, 1169], "text": "uk", "confidence": "Low"}, {"boundingBox": [471, 1135, 525, 1134, 525, 1169, 471, 1169], "text": "from"}, {"boundingBox": [538, 1134, 583, 1134, 583, 1169, 538, 1169], "text": "21\""}, {"boundingBox": [589, 1135, 683, 1135, 683, 1169, 589, 1169], "text": "January"}, {"boundingBox": [688, 1135, 752, 1136, 752, 1170, 688, 1169], "text": "2012.", "confidence": "Low"}]}, {"boundingBox": [172, 1182, 988, 1183, 987, 1219, 171, 1218], "text": "Use of pioglitazone is now contraindicated in patients with", "words": [{"boundingBox": [273, 1184, 319, 1184, 317, 1218, 271, 1217], "text": "Use", "confidence": "Low"}, {"boundingBox": [326, 1184, 352, 1185, 350, 1218, 324, 1218], "text": "of"}, {"boundingBox": [359, 1185, 509, 1186, 507, 1219, 357, 1218], "text": "pioglitazone"}, {"boundingBox": [516, 1186, 538, 1186, 536, 1220, 514, 1219], "text": "is"}, {"boundingBox": [544, 1186, 597, 1186, 595, 1220, 542, 1220], "text": "now"}, {"boundingBox": [606, 1186, 789, 1185, 787, 1220, 604, 1220], "text": "contraindicated"}, {"boundingBox": [796, 1185, 820, 1185, 818, 1219, 794, 1220], "text": "in"}, {"boundingBox": [827, 1185, 926, 1184, 924, 1219, 825, 1219], "text": "patients"}, {"boundingBox": [932, 1184, 988, 1183, 986, 1218, 931, 1219], "text": "with"}]}, {"boundingBox": [322, 1237, 703, 1239, 702, 1266, 321, 1265], "text": "current active bladder cancer or", "words": [{"boundingBox": [325, 1238, 414, 1239, 413, 1266, 324, 1265], "text": "current"}, {"boundingBox": [419, 1239, 492, 1239, 491, 1266, 418, 1266], "text": "active"}, {"boundingBox": [497, 1239, 591, 1239, 591, 1266, 497, 1266], "text": "bladder", "confidence": "Low"}, {"boundingBox": [596, 1239, 676, 1239, 676, 1266, 596, 1266], "text": "cancer"}, {"boundingBox": [681, 1239, 702, 1239, 702, 1266, 681, 1266], "text": "or", "confidence": "Low"}]}, {"boundingBox": [324, 1284, 677, 1285, 676, 1317, 323, 1316], "text": "a history of bladder cancer or", "words": [{"boundingBox": [326, 1287, 340, 1287, 340, 1317, 327, 1317], "text": "a"}, {"boundingBox": [345, 1287, 430, 1285, 430, 1316, 346, 1317], "text": "history"}, {"boundingBox": [436, 1285, 463, 1285, 463, 1316, 436, 1316], "text": "of"}, {"boundingBox": [469, 1285, 563, 1285, 563, 1316, 469, 1316], "text": "bladder"}, {"boundingBox": [569, 1285, 649, 1287, 649, 1317, 568, 1316], "text": "cancer"}, {"boundingBox": [655, 1287, 676, 1288, 676, 1318, 655, 1317], "text": "or", "confidence": "Low"}]}, {"boundingBox": [319, 1331, 814, 1331, 814, 1364, 320, 1365], "text": "uninvestigated macroscopic haematuria.", "words": [{"boundingBox": [324, 1333, 502, 1335, 502, 1365, 324, 1362], "text": "uninvestigated"}, {"boundingBox": [508, 1335, 662, 1334, 662, 1365, 508, 1365], "text": "macroscopic"}, {"boundingBox": [668, 1334, 814, 1331, 814, 1364, 668, 1365], "text": "haematuria."}]}, {"boundingBox": [138, 1430, 1367, 1433, 1366, 1467, 137, 1464], "text": "at Risk factors for bladder cancer should be assessed before initiating pioglitazone treatment", "words": [{"boundingBox": [139, 1432, 175, 1432, 175, 1459, 138, 1459], "text": "at", "confidence": "Low"}, {"boundingBox": [273, 1433, 330, 1433, 329, 1462, 272, 1461], "text": "Risk"}, {"boundingBox": [337, 1433, 420, 1433, 420, 1464, 336, 1462], "text": "factors"}, {"boundingBox": [425, 1433, 462, 1434, 461, 1464, 425, 1464], "text": "for"}, {"boundingBox": [467, 1434, 560, 1434, 560, 1465, 466, 1464], "text": "bladder"}, {"boundingBox": [566, 1434, 649, 1434, 649, 1466, 565, 1465], "text": "cancer"}, {"boundingBox": [654, 1434, 734, 1434, 734, 1466, 654, 1466], "text": "should"}, {"boundingBox": [739, 1434, 770, 1434, 770, 1466, 739, 1466], "text": "be"}, {"boundingBox": [775, 1434, 879, 1434, 880, 1467, 776, 1466], "text": "assessed"}, {"boundingBox": [885, 1434, 964, 1434, 965, 1466, 885, 1467], "text": "before", "confidence": "Low"}, {"boundingBox": [970, 1434, 1080, 1434, 1081, 1466, 970, 1466], "text": "initiating"}, {"boundingBox": [1086, 1434, 1237, 1434, 1237, 1464, 1086, 1466], "text": "pioglitazone"}, {"boundingBox": [1242, 1434, 1363, 1433, 1364, 1462, 1243, 1464], "text": "treatment"}]}, {"boundingBox": [274, 1468, 1251, 1469, 1250, 1499, 273, 1498], "text": "Any unexplained macroscopic haematuria should be investigated before starting", "words": [{"boundingBox": [276, 1469, 324, 1469, 325, 1498, 277, 1498], "text": "Any"}, {"boundingBox": [329, 1469, 480, 1469, 481, 1499, 330, 1498], "text": "unexplained"}, {"boundingBox": [486, 1469, 642, 1469, 643, 1499, 486, 1499], "text": "macroscopic"}, {"boundingBox": [647, 1469, 781, 1469, 782, 1499, 648, 1499], "text": "haematuria"}, {"boundingBox": [787, 1469, 869, 1469, 870, 1499, 788, 1499], "text": "should"}, {"boundingBox": [875, 1469, 906, 1469, 907, 1499, 876, 1499], "text": "be"}, {"boundingBox": [912, 1469, 1058, 1469, 1060, 1499, 913, 1499], "text": "investigated"}, {"boundingBox": [1064, 1469, 1143, 1469, 1144, 1499, 1065, 1499], "text": "before"}, {"boundingBox": [1148, 1469, 1244, 1469, 1245, 1498, 1150, 1499], "text": "starting", "confidence": "Low"}]}, {"boundingBox": [263, 1502, 525, 1503, 525, 1535, 262, 1534], "text": "pioglitazone therapy", "words": [{"boundingBox": [272, 1506, 423, 1503, 424, 1531, 271, 1533], "text": "pioglitazone"}, {"boundingBox": [428, 1503, 524, 1505, 525, 1535, 429, 1531], "text": "therapy"}]}, {"boundingBox": [255, 1569, 1359, 1570, 1358, 1603, 254, 1602], "text": "Patients should be advised to promptly seek the attention of their physician if macroscopic", "words": [{"boundingBox": [272, 1570, 370, 1570, 370, 1600, 272, 1599], "text": "Patients"}, {"boundingBox": [376, 1570, 458, 1570, 458, 1601, 376, 1600], "text": "should"}, {"boundingBox": [463, 1570, 493, 1570, 493, 1602, 463, 1601], "text": "be"}, {"boundingBox": [499, 1570, 594, 1570, 594, 1602, 499, 1602], "text": "advised"}, {"boundingBox": [599, 1570, 625, 1570, 625, 1603, 599, 1602], "text": "to"}, {"boundingBox": [631, 1570, 743, 1570, 742, 1603, 631, 1603], "text": "promptly"}, {"boundingBox": [748, 1570, 804, 1570, 804, 1603, 748, 1603], "text": "seek"}, {"boundingBox": [810, 1570, 849, 1570, 849, 1604, 809, 1603], "text": "the"}, {"boundingBox": [854, 1570, 962, 1570, 962, 1604, 854, 1604], "text": "attention"}, {"boundingBox": [968, 1570, 994, 1570, 994, 1603, 968, 1604], "text": "of"}, {"boundingBox": [1000, 1570, 1056, 1571, 1055, 1603, 999, 1603], "text": "their"}, {"boundingBox": [1061, 1571, 1178, 1571, 1178, 1603, 1061, 1603], "text": "physician"}, {"boundingBox": [1184, 1571, 1206, 1571, 1206, 1603, 1184, 1603], "text": "if"}, {"boundingBox": [1212, 1571, 1359, 1571, 1359, 1602, 1212, 1603], "text": "macroscopic"}]}, {"boundingBox": [268, 1604, 1379, 1605, 1378, 1635, 267, 1634], "text": "haematuria or other symptoms such as dysuria or urinary urgency develop during treatment.", "words": [{"boundingBox": [272, 1606, 408, 1607, 409, 1634, 273, 1632], "text": "haematuria"}, {"boundingBox": [413, 1607, 441, 1607, 442, 1634, 415, 1634], "text": "or"}, {"boundingBox": [446, 1607, 512, 1608, 513, 1634, 447, 1634], "text": "other"}, {"boundingBox": [517, 1608, 643, 1608, 644, 1635, 518, 1634], "text": "symptoms"}, {"boundingBox": [648, 1608, 703, 1609, 705, 1636, 649, 1635], "text": "such"}, {"boundingBox": [708, 1609, 740, 1609, 741, 1636, 710, 1636], "text": "as"}, {"boundingBox": [745, 1609, 833, 1609, 834, 1636, 746, 1636], "text": "dysuria"}, {"boundingBox": [838, 1609, 865, 1609, 867, 1636, 839, 1636], "text": "or"}, {"boundingBox": [871, 1609, 959, 1608, 960, 1636, 872, 1636], "text": "urinary"}, {"boundingBox": [964, 1608, 1064, 1608, 1065, 1636, 965, 1636], "text": "urgency"}, {"boundingBox": [1071, 1608, 1166, 1607, 1167, 1635, 1072, 1635], "text": "develop"}, {"boundingBox": [1176, 1607, 1252, 1607, 1253, 1634, 1177, 1635], "text": "during"}, {"boundingBox": [1257, 1606, 1376, 1605, 1378, 1633, 1259, 1634], "text": "treatment."}]}, {"boundingBox": [259, 1673, 1310, 1674, 1310, 1709, 258, 1708], "text": "\"In light of age-related risks (especially bladder cancer, fractures and heart failure), the", "words": [{"boundingBox": [259, 1675, 298, 1675, 298, 1706, 259, 1706], "text": "\"In", "confidence": "Low"}, {"boundingBox": [304, 1675, 361, 1676, 361, 1707, 304, 1706], "text": "light"}, {"boundingBox": [367, 1676, 394, 1676, 394, 1707, 367, 1707], "text": "of"}, {"boundingBox": [400, 1676, 535, 1677, 535, 1708, 400, 1707], "text": "age-related"}, {"boundingBox": [541, 1677, 600, 1677, 600, 1709, 541, 1709], "text": "risks"}, {"boundingBox": [606, 1677, 737, 1677, 737, 1709, 606, 1709], "text": "(especially"}, {"boundingBox": [743, 1677, 835, 1677, 835, 1709, 743, 1709], "text": "bladder"}, {"boundingBox": [841, 1677, 931, 1677, 931, 1709, 842, 1709], "text": "cancer,"}, {"boundingBox": [938, 1677, 1044, 1676, 1044, 1709, 938, 1709], "text": "fractures"}, {"boundingBox": [1050, 1676, 1093, 1676, 1093, 1708, 1050, 1708], "text": "and"}, {"boundingBox": [1099, 1676, 1160, 1676, 1160, 1708, 1099, 1708], "text": "heart"}, {"boundingBox": [1166, 1675, 1265, 1674, 1265, 1707, 1166, 1708], "text": "failure),"}, {"boundingBox": [1271, 1674, 1310, 1674, 1310, 1706, 1271, 1707], "text": "the"}]}, {"boundingBox": [274, 1709, 1392, 1710, 1391, 1741, 273, 1740], "text": "balance of benefits and risks should be considered carefully before initiating treatment in the", "words": [{"boundingBox": [276, 1711, 366, 1711, 365, 1738, 274, 1738], "text": "balance"}, {"boundingBox": [371, 1711, 399, 1711, 398, 1739, 370, 1739], "text": "of"}, {"boundingBox": [404, 1711, 503, 1711, 502, 1740, 403, 1739], "text": "benefits"}, {"boundingBox": [509, 1711, 552, 1710, 551, 1740, 508, 1740], "text": "and"}, {"boundingBox": [557, 1710, 618, 1710, 617, 1740, 556, 1740], "text": "risks"}, {"boundingBox": [624, 1710, 705, 1710, 704, 1741, 623, 1740], "text": "should"}, {"boundingBox": [711, 1710, 742, 1710, 741, 1741, 710, 1741], "text": "be"}, {"boundingBox": [747, 1710, 879, 1710, 879, 1741, 746, 1741], "text": "considered"}, {"boundingBox": [885, 1710, 994, 1710, 994, 1741, 884, 1741], "text": "carefully"}, {"boundingBox": [999, 1710, 1078, 1710, 1077, 1741, 999, 1741], "text": "before"}, {"boundingBox": [1083, 1710, 1194, 1710, 1194, 1740, 1083, 1741], "text": "initiating"}, {"boundingBox": [1200, 1710, 1314, 1711, 1314, 1740, 1199, 1740], "text": "treatment"}, {"boundingBox": [1320, 1711, 1346, 1711, 1346, 1739, 1320, 1740], "text": "in"}, {"boundingBox": [1351, 1711, 1391, 1711, 1391, 1739, 1351, 1739], "text": "the"}]}, {"boundingBox": [269, 1744, 365, 1741, 366, 1768, 270, 1772], "text": "elderly.", "words": [{"boundingBox": [274, 1745, 366, 1742, 365, 1770, 274, 1771], "text": "elderly.", "confidence": "Low"}]}, {"boundingBox": [1271, 1826, 1409, 1823, 1410, 1848, 1272, 1850], "text": "Takeda UK Lid.", "words": [{"boundingBox": [1278, 1828, 1338, 1827, 1338, 1849, 1278, 1849], "text": "Takeda"}, {"boundingBox": [1342, 1827, 1367, 1826, 1368, 1849, 1342, 1849], "text": "UK", "confidence": "Low"}, {"boundingBox": [1371, 1826, 1410, 1824, 1410, 1848, 1372, 1849], "text": "Lid.", "confidence": "Low"}]}, {"boundingBox": [834, 1995, 855, 1854, 881, 1858, 861, 1999], "text": "PENGAD 800-631-50", "words": [{"boundingBox": [837, 1995, 843, 1939, 866, 1942, 862, 1999], "text": "PENGAD"}, {"boundingBox": [844, 1934, 858, 1855, 882, 1858, 867, 1937], "text": "800-631-50", "confidence": "Low"}]}, {"boundingBox": [940, 1853, 1034, 1865, 1030, 1894, 936, 1883], "text": "EXHIBIT", "words": [{"boundingBox": [942, 1855, 1034, 1865, 1030, 1895, 939, 1883], "text": "EXHIBIT"}]}, {"boundingBox": [1149, 1851, 1406, 1854, 1406, 1881, 1148, 1878], "text": "Takeda House, Mercury Park,", "words": [{"boundingBox": [1156, 1853, 1215, 1854, 1216, 1879, 1156, 1878], "text": "Takeda"}, {"boundingBox": [1220, 1854, 1279, 1855, 1280, 1880, 1220, 1879], "text": "House,"}, {"boundingBox": [1284, 1855, 1357, 1855, 1357, 1881, 1284, 1880], "text": "Mercury", "confidence": "Low"}, {"boundingBox": [1361, 1855, 1406, 1854, 1406, 1881, 1362, 1881], "text": "Park,", "confidence": "Low"}]}, {"boundingBox": [1141, 1883, 1409, 1884, 1409, 1910, 1140, 1909], "text": "ycombe Lane. Wooburn Green,", "words": [{"boundingBox": [1141, 1885, 1210, 1884, 1211, 1909, 1142, 1909], "text": "ycombe", "confidence": "Low"}, {"boundingBox": [1214, 1884, 1260, 1884, 1261, 1909, 1215, 1909], "text": "Lane.", "confidence": "Low"}, {"boundingBox": [1265, 1884, 1345, 1884, 1345, 1909, 1265, 1909], "text": "Wooburn", "confidence": "Low"}, {"boundingBox": [1350, 1884, 1408, 1885, 1408, 1910, 1350, 1910], "text": "Green,", "confidence": "Low"}]}, {"boundingBox": [949, 1910, 1007, 1917, 1004, 1952, 944, 1944], "text": "5:3", "words": [{"boundingBox": [952, 1909, 1005, 1916, 1001, 1951, 948, 1944], "text": "5:3", "confidence": "Low"}]}, {"boundingBox": [1175, 1913, 1400, 1911, 1401, 1937, 1175, 1939], "text": "High Wycombe HP10 OHH", "words": [{"boundingBox": [1178, 1913, 1218, 1913, 1220, 1939, 1180, 1940], "text": "High"}, {"boundingBox": [1224, 1913, 1313, 1913, 1314, 1938, 1225, 1939], "text": "Wycombe", "confidence": "Low"}, {"boundingBox": [1318, 1913, 1362, 1913, 1362, 1938, 1319, 1938], "text": "HP10", "confidence": "Low"}, {"boundingBox": [1367, 1913, 1400, 1912, 1401, 1937, 1368, 1938], "text": "OHH", "confidence": "Low"}]}, {"boundingBox": [1228, 1960, 1409, 1959, 1410, 1985, 1229, 1986], "text": "5. +410)1628 537900", "words": [{"boundingBox": [1229, 1962, 1244, 1962, 1245, 1985, 1230, 1985], "text": "5.", "confidence": "Low"}, {"boundingBox": [1249, 1961, 1341, 1960, 1342, 1986, 1250, 1985], "text": "+410)1628", "confidence": "Low"}, {"boundingBox": [1346, 1960, 1409, 1960, 1410, 1986, 1346, 1986], "text": "537900", "confidence": "Low"}]}, {"boundingBox": [1218, 1990, 1419, 1988, 1420, 2013, 1219, 2015], "text": "F+44(0)1628 526015-", "words": [{"boundingBox": [1229, 1991, 1342, 1990, 1342, 2015, 1229, 2015], "text": "F+44(0)1628", "confidence": "Low"}, {"boundingBox": [1347, 1990, 1420, 1989, 1419, 2015, 1346, 2015], "text": "526015-", "confidence": "Low"}]}, {"boundingBox": [1235, 2035, 1402, 2033, 1403, 2057, 1236, 2059], "text": "www.takeda.co.uk", "words": [{"boundingBox": [1245, 2037, 1403, 2034, 1402, 2059, 1244, 2058], "text": "www.takeda.co.uk", "confidence": "Low"}]}, {"boundingBox": [37, 2148, 537, 2150, 536, 2176, 36, 2174], "text": "\"Confidential Subject to Protective Order", "words": [{"boundingBox": [38, 2149, 224, 2150, 223, 2175, 37, 2172], "text": "\"Confidential", "confidence": "Low"}, {"boundingBox": [242, 2150, 322, 2150, 321, 2176, 241, 2175], "text": "Subject"}, {"boundingBox": [326, 2150, 349, 2150, 348, 2176, 325, 2176], "text": "to"}, {"boundingBox": [353, 2150, 461, 2151, 460, 2176, 352, 2176], "text": "Protective"}, {"boundingBox": [467, 2151, 533, 2151, 533, 2175, 467, 2176], "text": "Order"}]}, {"boundingBox": [1214, 2149, 1536, 2146, 1536, 2172, 1215, 2176], "text": "\"TAK-TYNANJ-00213198proxy", "words": [{"boundingBox": [1215, 2151, 1535, 2146, 1534, 2171, 1215, 2174], "text": "\"TAK-TYNANJ-00213198proxy", "confidence": "Low"}]}, {"boundingBox": [376, 2195, 1316, 2193, 1317, 2231, 377, 2233], "text": "Source: https://www.indup544qcooouts.ucsf.edu/docs/psjf0226", "words": [{"boundingBox": [384, 2198, 500, 2198, 501, 2231, 385, 2230], "text": "Source:"}, {"boundingBox": [506, 2198, 1315, 2194, 1316, 2229, 507, 2231], "text": "https://www.indup544qcooouts.ucsf.edu/docs/psjf0226", "confidence": "Low"}]}]}]}